Target intelligence / Profile preview

RNA, U6 small nuclear 509, pseudogene (RNU6-509P)

Target: RNU6-509P
Molecular classification: Pseudogene

Overview

RNU6-509P is a pseudogene copy of the U6 small nuclear RNA gene, identified as pseudogene number 509 in the current human genome annotations. Pseudogenes are genetic sequences resembling functional genes but do not produce functional RNA or protein products due to mutations, truncation, or lack of proper regulatory sequences[7]. The original U6 snRNA plays a central role in pre-mRNA splicing via the spliceosome in eukaryotic cells[1][3], but pseudogene copies like RNU6-509P are relics from genome evolution, commonly propagated by retrotransposition mechanisms[4][5]. They typically lack biological function and are not associated with disease or pharmacology[7].

Other names: RNU6-509P

Mechanism of action

None applicable. No mechanism of action established for drugs targeting this molecule, as no known drugs or therapeutic agents target it.

Biological functions

None. Pseudogenes by definition do not encode active biological molecules. Functional roles are limited to possible gene regulation through non-coding RNA effects in some rare cases, but not documented for RNU6-509P.

Disease associations

None. No established roles in disease, cancer, inflammation, infection, or other pathology. U6 snRNA pseudogenes generally serve as markers of retrotransposition in genome evolution rather than affecting disease[4].

Safety considerations

None. Pseudogenes do not encode functional products, so there are no documented therapeutic or safety issues associated with RNU6-509P.

Interacting drugs

None. No drugs are reported to interact with RNU6-509P or other U6 snRNA pseudogenes.

Biomarkers

None. Not used as a biomarker for patient selection, monitoring, or efficacy.

Beyond the preview

Go deeper on RNA, U6 small nuclear 509, pseudogene (RNU6-509P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 509, pseudogene (RNU6-509P).

Explore the full profile